Low-level Expression of MicroRNAs Let-7d and MiR-205 Are Prognostic Markers of Head and Neck Squamous Cell Carcinoma

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2009 Jan 31

PMID 19179615

Citations 166

Authors

Geoffrey Childs

Melissa Fazzari

Gloria Kung

Nicole Kawachi

Margaret Brandwein-Gensler

Michael McLemore

Quan Chen

Robert D Burk

Richard V Smith

Michael B Prystowsky

Thomas J Belbin

Nicolas F Schlecht

Affiliations

Soon will be listed here.

Abstract

Small noncoding microRNAs (miRNAs) have been shown to be abnormally expressed in every tumor type examined. The importance of miRNAs as potential cancer prognostic indicators is underscored by their involvement in the regulation of basic cellular processes such as cell proliferation, differentiation, and apoptosis. In this study, miRNA expression profiles of head and neck squamous cell carcinoma (HNSCC) tumor and adjacent normal tissue were examined by microarray analysis and validated by quantitative TaqMan real-time polymerase chain reaction. Using TaqMan real-time polymerase chain reaction we measured the quantitative associations between a subset of miRNAs identified on microarrays in primary tumors at diagnosis and cancer survival in a cohort of 104 HNSCC patients undergoing treatment with curative intent. The majority of miRNAs exhibiting altered expression in primary human HNSCC tumors (including miR-1, miR-133a, miR-205, and let-7d) show lower expression levels relative to normal adjacent tissue. In contrast, hsa-miR-21 is frequently overexpressed in human HNSCC tumors. Using univariate and multivariable statistical models we show that low levels of hsa-miR205 are significantly associated with loco-regional recurrence independent of disease severity at diagnosis and treatment. In addition, combined low levels of hsa-miR-205 and hsa-let-7d expression in HNSCC tumors are significantly associated with poor head and neck cancer survival Our results show that miRNA expression levels can be used as prognostic markers of head and neck cancer.

Citing Articles

Interaction of the tumor suppressor SMAD4 and WNT signaling in progression to oral squamous cell carcinoma.

Yang J, Lewis J, Zi J, Andl T, Lee E, Andl C J Pathol. 2024; 264(1):4-16.

PMID: 38922866 PMC: 11300146. DOI: 10.1002/path.6318.

miRNA Associated With Glucose Transporters in Oral Squamous Cell Carcinoma: A Systematic Review.

R Jr P, Yuwanati M, Sekaran S, M S Cureus. 2023; 15(9):e46057.

PMID: 37900425 PMC: 10605560. DOI: 10.7759/cureus.46057.

The Potential microRNA Prognostic Signature in HNSCCs: A Systematic Review.

Dioguardi M, Spirito F, Iacovelli G, Sovereto D, Laneve E, Laino L Noncoding RNA. 2023; 9(5).

PMID: 37736900 PMC: 10514860. DOI: 10.3390/ncrna9050054.

Survival associated miRNA signature in patients with head and neck carcinomas.

Yerukala Sathipati S, Ho S Heliyon. 2023; 9(6):e17218.

PMID: 37360084 PMC: 10285236. DOI: 10.1016/j.heliyon.2023.e17218.

An insight into the associations between microRNA expression and mitochondrial functions in cancer cell and cancer stem cell.

Tan W, Subha S, Mohtarrudin N, Cheah Y Mol Biol Rep. 2023; 50(6):5395-5405.

PMID: 37074612 DOI: 10.1007/s11033-023-08421-5.

References

Yu S, Chen H, Chang G, Chen C, Chen H, Singh S . MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008; 13(1):48-57. DOI: 10.1016/j.ccr.2007.12.008. View

Belbin T, Singh B, Barber I, Socci N, Wenig B, Smith R . Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res. 2002; 62(4):1184-90. View

Zhang L, Huang J, Yang N, Greshock J, Megraw M, Giannakakis A . microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci U S A. 2006; 103(24):9136-41. PMC: 1474008. DOI: 10.1073/pnas.0508889103. View

Hebert C, Norris K, Scheper M, Nikitakis N, Sauk J . High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer. 2007; 6:5. PMC: 1783857. DOI: 10.1186/1476-4598-6-5. View

Johnson S, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A . RAS is regulated by the let-7 microRNA family. Cell. 2005; 120(5):635-47. DOI: 10.1016/j.cell.2005.01.014. View

Asangani I, Rasheed S, Nikolova D, Leupold J, Colburn N, Post S . MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2007; 27(15):2128-36. DOI: 10.1038/sj.onc.1210856. View

Kent O, Mendell J . A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 2006; 25(46):6188-96. DOI: 10.1038/sj.onc.1209913. View

Pedrero J, Carracedo D, Pinto C, Zapatero A, Rodrigo J, Suarez Nieto C . Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma. Int J Cancer. 2004; 114(2):242-8. DOI: 10.1002/ijc.20711. View

Chang T, Yu D, Lee Y, Wentzel E, Arking D, West K . Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet. 2007; 40(1):43-50. PMC: 2628762. DOI: 10.1038/ng.2007.30. View

10.

Kyzas P, Stefanou D, Batistatou A, Agnantis N . Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol. 2005; 131(9):624-30. DOI: 10.1007/s00432-005-0003-6. View

11.

Poetsch M, Lorenz G, Kleist B . Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10. Cancer Genet Cytogenet. 2002; 132(1):20-4. DOI: 10.1016/s0165-4608(01)00509-x. View

12.

Hanna E, Shrieve D, Ratanatharathorn V, Xia X, Breau R, Suen J . A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck. Cancer Res. 2001; 61(6):2376-80. View

13.

Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M . Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9(3):189-98. DOI: 10.1016/j.ccr.2006.01.025. View

14.

Magro P, Russo A, Li W, Banerjee D, Bertino J . p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53. Cancer Res. 2004; 64(12):4338-45. DOI: 10.1158/0008-5472.CAN-03-1045. View

15.

Hildesheim A, Schiffman M, Gravitt P, Glass A, Greer C, Zhang T . Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994; 169(2):235-40. DOI: 10.1093/infdis/169.2.235. View

16.

Warner G, Reis P, Jurisica I, Sultan M, Arora S, MacMillan C . Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int J Cancer. 2004; 110(6):857-68. DOI: 10.1002/ijc.20197. View

17.

Leethanakul C, Knezevic V, Patel V, Amornphimoltham P, Gillespie J, Shillitoe E . Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol. 2003; 39(3):248-58. DOI: 10.1016/s1368-8375(02)00107-0. View

18.

Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J . Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 2008; 68(7):2094-105. DOI: 10.1158/0008-5472.CAN-07-5194. View

19.

McShane L, Altman D, Sauerbrei W, Taube S, Gion M, Clark G . Reporting recommendations for tumor marker prognostic studies. J Clin Oncol. 2005; 23(36):9067-72. DOI: 10.1200/JCO.2004.01.0454. View

20.

Ambros V . microRNAs: tiny regulators with great potential. Cell. 2002; 107(7):823-6. DOI: 10.1016/s0092-8674(01)00616-x. View